RKAM
RKAMCIK 0002087716
No XBRL size data yet — common for recent IPOs and new registrants (SEC companyfacts lag), foreign filers reporting in non-USD, or non-standard filers.
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (PURR 10-K) is open in full — no account needed.
S-1/A
Filed Jun 4, 2026
Red flag
RKAM prices $25M IPO at $9.50/share; company nets $21.9M for organ regeneration and supplements
5 material changes detected. Sign up free to read the summary.